- Lifeist Wellness Inc. (LFST) has launched a new biosciences and consumer wellness company called Mikra, Cellular Sciences Inc.
- MLB player Jose Bautista is joining the company as an advisor and is making a direct equity investment in Lifeist
- Mikra is in the production stages of its first product, Alpha-01, manufactured in a proprietary, oxygen-deprived environment, utilizing clinically tested, clinical-grade ingredients sourced only from the U.S. and Japan
- Pre-sale activities are scheduled for December 2021 with full distribution across Lifeist’s upcoming in-house direct-to-consumer platform and through Amazon in late Q1 2022 with offline distribution scheduled in Q4 2022
- Lifeist has completed a non-brokered private placement by two subscribers including an investment vehicle of Mr. Bautista, of an aggregate of 2,214,287 units of Lifeist at a price of $0.07 per unit for aggregate gross proceeds of $155,000.09
- Lifeist Wellness Inc. (LFST) is up 25 per cent and is trading at $0.10 per share as of 4:16 p.m. EST
Lifeist Wellness (LFST) has launched a new biosciences and consumer wellness company called Mikra, Cellular Sciences Inc.
As part of the nutraceuticals endeavour, Lifeist is collaborating with MLB player Jose Bautista, who is joining the company as an advisor and is making a direct equity investment in Lifeist.
Mikra is driven by a single element, focusing on the tiniest aspect of one’s health that has the largest impact which is the cell.
It is is exploring the link between changes at a cellular level and the cascading effects it can have on health.
Mikra’s review of the nutraceuticals market uncovered an exceptional amount of misleading marketing and hyperbolized claims in the industry.
Mikra is in the final production stages of its first product, Alpha-01, which is manufactured in a proprietary, oxygen-deprived environment, utilizing clinically tested, clinical-grade ingredients sourced only from the U.S. and Japan.
Its first product seeks to become one of the world’s most potent bioactive compounds targeting cellular stress.
Alpha-01 works at a cellular level to effectively increase one’s everyday performance and potential.
Pre-sale activities are scheduled for December 2021 with full distribution across Lifeist’s upcoming in-house direct-to-consumer platform and through Amazon in late Q1 2022 with offline distribution scheduled in Q4 2022.
Lifeist has completed a non-brokered private placement by two subscribers including an investment vehicle of Mr. Bautista, of an aggregate of 2,214,287 units of Lifeist at a price of $0.07 per unit for aggregate gross proceeds of $155,000.09.
Each unit consists of one common share of Lifeist and one share purchase warrant.
Each warrant entitles subscribers to acquire one Share at an exercise price of $0.11 until November 29, 2024.
The proceeds of the offering will be used towards the development of Mikra’s product pipeline.
The shares constitute approximately 0.55 per cent of the issued shares of Lifeist and the warrants are subject to a statutory hold period of four months and one day.
Any warrants exercised on or prior to March 30, 2022, will also be subject to the same hold period ending on March 30, 2022.
Lifeist Wellness Inc. (LFST) is up 25 per cent and is trading at $0.10 per share as of 4:16 p.m. EST.
